首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Polymer based microspheres of aceclofenac as sustained release parenterals for prolonged anti-inflammatory effect
【24h】

Polymer based microspheres of aceclofenac as sustained release parenterals for prolonged anti-inflammatory effect

机译:基于聚合物的醋氯芬酸的微球,持续释放肠胃外,延长抗炎作用

获取原文
获取原文并翻译 | 示例
       

摘要

Poly(lactic-co-glycolic acid) (PLGA) (75:25) and polycaprolactone (PCL) microspheres were fabricated for prolonged release of aceclofenac by parenteral administration. Microspheres encapsulating aceclofenac were designed to release the drug at controlled rate for around one month. Biodegradable microspheres were prepared by solvent emulsification evaporation method in different polymer:drug ratios (1:1, 2:1 and 3:1). After drug loading, PLGA and PCL microspheres showed a controlled size distribution with an average size of 11.75 mu m and 3.81 mu m respectively and entrapment efficiency in the range of 90 +/- 0.72% to 91.06 +/- 4.01% with PLGA and 83.01 +/- 2.13% to 90.4 +/- 2.11% with PCL. Scanning electron microscopy has confirmed good spherical structures of microspheres. The percent yield of biodegradable polymeric microspheres ranged between 30.95 +/- 10.14% to 92.84 +/- 3.15% and 47.33 +/- 4.72% to 80 +/- 3.60% for PLGA and PCL. microspheres respectively. PLGA microspheres followed Higuchi release pattern while Korsmeyer-Peppas explained the release pattern of PCL microspheres. Stability studies of microspheres were also carried out by storing the preparations at 2-8 degrees C for 30, 60 and 90 days and evaluating them for entrapment efficiency, residual drug content and polymer drug compatability. In-vivo studies showed significant anti-inflammatory activity of microspheres upto 48 hours using the carrageenan induced rat paw oedema model. (C) 2016 Elsevier B.V. All rights reserved.
机译:制备聚(乳酸共聚乙醇酸)(PLGA)(75:25)和聚己内酯(PCL)微球,用于通过肠胃外给药延长丙烯烃。封装醋氯芬酸的微球被设计成以受控速率释放药物左右。通过不同聚合物中的溶剂乳化蒸发方法制备可生物降解的微球:药物比(1:1,2:1和3:1)。在药物加载后,PLGA和PCL微球显示出平均尺寸的受控尺寸分布,平均尺寸为11.75μm和3.81μm,分别为90 +/- 0.72%至91.06 +/- 4.01%的滞留效率,PLGA和83.01 +/- 2.1.13%至90.4 +/- 2.11%,PCL。扫描电子显微镜已经证实了微球的良好球形结构。可生物降解聚合物微球的产率为30.95 +/- 10.14%至92.84 +/- 3.15%和47.33 +/- 4.72%至80 +/- 3.60%,PCL和PCL。微球分别。 PLGA微球遵循Higuchi释放模式,而Korsmeyer-Peppas解释了PCL微球的释放模式。还通过将制剂在2-8℃下储存30,60和90天,并评估夹带效率,残留药物含量和聚合物药物相容性来进行微球的稳定性研究。体内研究表明,使用角叉菜胶诱导的大鼠爪子水肿模型表明,48小时的微球的显着抗炎活性。 (c)2016年Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号